IRISH JIAN (Chief Executive Officer) sold 0.5% of their position (1.60K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/1/2025ACC: 0001193125-25-304212
DirectorOfficer· Chief Executive Officer
Since Dec 2025
+471.90K
Net shares
Net buyer
$2.9K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
473.50K acquired · 1.60K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.60K
Price / share
$1.81
Trade value
$2.90K
% of position
0.5%
9/5/2025
318.54K→316.94K
Common Stock
Direct
Shares
+37.50K
Price / share
$1.60
Trade value
$60K
% of position
11.8%
12/1/2025
316.94K→354.44K
Common Stock
Direct
Shares
+211K
Price / share
$1.60
Trade value
$337.60K
% of position
59.5%
12/1/2025
354.44K→565.44K
Total
Net shares
+246.90K
Net value
$394.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2025 | S · Sale | −1.60K | $1.81 | $2.90K | 0.5% | 318.54K | 316.94K |
| Common Stock Direct | 12/1/2025 | A · Award | +37.50K | $1.60 | $60K | 11.8% | 316.94K | 354.44K |
| Common Stock Direct | 12/1/2025 | A · Award | +211K | $1.60 | $337.60K | 59.5% | 354.44K | 565.44K |
| Total | +246.90K | $394.70K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
225K shares
Shares
+225K
Strike price
1.60
Held after
225K
Exercisable
—
12/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock225K shares | 12/1/2025 | A · Award | +225K | 1.60 | — | 225K |